BIIB beats Street EPS

Biogen Idec (BIIB) reported third quarter adjusted EPS of $0.37, beating the Street estimate by $0.02 and up 6% from

Read the full 206 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE